Atlas Trials

Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT01261494 · COMPLETED

Trial details

NCT number
NCT01261494
Sponsor
Genfit
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type II Diabetes Mellitus
Start date
2010-12-01
Primary completion
2011-06-01
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.